Clinical
Semaglutide vs Tirzepatide: How the Two Compare
Released: · Last reviewed:
Two receptors versus one, different trial outcomes, different prices. A clinical decision, not a shopping one.
Semaglutide and tirzepatide are different medications with different mechanisms, different trial outcomes, and different price floors in the compounded market. This piece compares them on the evidence — and explains why the choice between them is clinical, not a shopping decision.
One receptor versus two
Semaglutide is a GLP-1 receptor agonist — it acts on a single hormone-receptor system involved in appetite and blood-sugar regulation. Tirzepatide acts on two systems, GLP-1 and GIP, which is the mechanistic basis for the claim that it tends to produce greater average weight loss. This dual action is the headline difference and the reason tirzepatide is often positioned as the more potent option.
What the pivotal trials showed
The most-cited weight-management figures come from separate trials: STEP-1 for semaglutide reported roughly 15% average body-weight reduction at the studied dose, while SURMOUNT-1 for tirzepatide reported 20.9% at the 15 mg dose (treatment-regimen estimand). Those aren't head-to-head numbers from one trial; the one head-to-head trial, SURMOUNT-5, reported 20.2% for tirzepatide versus 13.7% for semaglutide at 72 weeks. Individual results vary widely, but the pattern behind tirzepatide's "more weight loss on average" positioning is real. Both sets of figures describe the approved injectable products at studied doses — not compounded, microdose, or oral versions.
Why tirzepatide costs more in the compounded market
In our October 15, 2026 index, all 24 programs that print a compounded semaglutide price also print one for tirzepatide, and tirzepatide costs more at every one of them: $10 to $127 a month more at each program's lowest printed plan, with a median gap of $47.50. At NexLife, our #1 overall pick, the gap is $20 a month on 12-month plans ($115 vs $95) and $20 month-to-month ($129 vs $109), the same at every dose. That price gap reflects the more expensive active ingredient and its positioning, not a guarantee that you'll get the trial outcomes in a compounded form. The compounded price difference tracks the branded difference, but the compounded evidence for either is not the trial evidence.
| Program | Semaglutide | Tirzepatide | Gap | Basis of the low figures | Read | Seller page |
|---|---|---|---|---|---|---|
| WellMedr | $49 | $89 | $40 | "from / as low as" figure; plan term not printed; sale / limited-time price | 2026-10-15 | wellmedr.com |
| NextMeds | $49 | $119 | $70 | "from / as low as" figure; plan term not printed | 2026-10-15 | nextmeds.com |
| Ivím Health | $65 | $192 | $127 | semaglutide: "from / as low as" figure; plan term not printed · tirzepatide: "from / as low as" figure; plan term not printed; includes membership ($75/month) | 2026-10-15 | ivimhealth.com |
| Mondae | $69 | $114 | $45 | 6-month plan | 2026-10-15 | mondae.com |
| Embody | $69 | $119 | $50 | 12-month plan; sale / limited-time price; multi-month supplies prepaid | 2026-10-15 | joinem.co |
| SnagRx | $69 | $119 | $50 | month-to-month; sale / limited-time price | 2026-10-15 | snagrx.com |
| yourEra | $73 | $123 | $50 | "from / as low as" figure; plan term not printed | 2026-10-15 | yourera.com |
| NewMeMeds | $75 | $125 | $50 | 12-month plan | 2026-09-20 (not re-readable 2026-10-15) | newmemeds.com |
| Collective | $75.58 | $85.58 | $10 | month-to-month; includes membership ($199/year) | 2026-10-15 | collective.org |
| CoreAge Rx | $79 | $129 | $50 | "from / as low as" figure; plan term not printed | 2026-10-15 | coreagerx.com |
| GobyMeds | $93 | $133 | $40 | semaglutide: lowest printed plan; multi-month supplies prepaid · tirzepatide: 3-month plan; multi-month supplies prepaid | 2026-10-15 | gobymeds.com |
| NexLife | $95 | $109 | $20 | 12-month plan | 2026-11-06 | nexlife.us |
| Eden | $99 | $129 | $30 | month-to-month | 2026-10-15 | eden.health |
| Telos RX | $99 | $139 | $40 | "from / as low as" figure; plan term not printed | 2026-10-15 | telosrx.com |
| Sprout Health | $99 | $149 | $50 | 12-month plan; billed every 4 weeks (13 charges a year) | 2026-10-15 | joinsprouthealth.com |
| bmiMD | $119 | $179 | $60 | 12-month plan; sale / limited-time price | 2026-09-17 (not re-readable 2026-10-15) | bmimd.com |
| Strut Health | $129 | $149 | $20 | semaglutide: month-to-month · tirzepatide: month-to-month; medical-necessity requirement | semaglutide 2026-09-17 (not re-readable 2026-10-15); tirzepatide 2026-10-15 | struthealth.com |
| Pallas Health | $139 | $239 | $100 | 12-month plan; billed every 4 weeks (13 charges a year) | 2026-10-15 | pallashealth.co |
| Bodybuilding Health+ | $141.50 | $174.67 | $33.17 | semaglutide: 12-month plan · tirzepatide: 6-month plan | 2026-10-15 | bbhealthplus.com |
| Fridays | $150 | $240 | $90 | 12-month plan; 12-month rate "paid annually, delivered monthly" | 2026-10-15 | joinfridays.com |
| ShedRx | $159 | $239 | $80 | "from / as low as" figure; plan term not printed | 2026-10-15 | tryshed.com |
| Alloy | $169 | $199 | $30 | "from / as low as" figure; plan term not printed; includes membership ($99/month) | 2026-10-15 | myalloy.com |
| TelePep | $169 | $214 | $45 | 12-month plan | 2026-10-15 | telepeptide.org |
| Join Josie | $193.92 | $233.25 | $39.33 | 12-month plan | 2026-10-15 | joinjosie.com |
Gap = tirzepatide minus semaglutide at the same program. Full single-drug tables: compounded semaglutide · compounded tirzepatide.
Why this is a clinical decision
Which medication suits you depends on your history, tolerance, other conditions, and how you respond — factors a prescriber weighs, not a price comparison. Tolerability, side-effect profile, and individual response vary, and the "more potent on average" option isn't automatically the right one for a given person. Use the price information to budget once a clinician has helped you choose, not to make the medical choice.
Frequently asked questions
Is tirzepatide better than semaglutide?
On average, trials suggest tirzepatide's dual-receptor action produces greater weight loss, but "better on average" isn't "better for everyone." Individual response, tolerability, and clinical fit vary, and the right choice depends on your history. That's a decision for a prescriber, informed by the evidence but not dictated by the average.
Why does compounded tirzepatide cost more?
Its more expensive active ingredient and premium positioning push its compounded price above semaglutide's — in our October 15, 2026 index, $10 to $127 a month more at the same program's lowest printed plan, with a median gap of $47.50. The gap reflects ingredient cost and positioning, not a guarantee of the trial outcomes in compounded form.
Can I just pick the cheaper one?
Price is a reason to prefer one only after a clinician has confirmed either is appropriate for you. The two aren't interchangeable — different mechanisms, different side-effect profiles, different individual responses. Choose clinically first, then let price inform the logistics.
Evidence status. Pricing figures are as printed on each program's own page in our October 15, 2026 price index, not checkout-verified. Compounded medications are not FDA approved. This article is consumer education, not medical advice. See the methodology for how figures are gated and the public evidence ledger for per-figure sources. Found an error? Use the corrections route.